Kenvue Inc. (KVUE)
Company Description
Kenvue is the world’s largest pure-play consumer health company by revenue with $15.1 billion in net sales in 2021.
We combine the power of science with meaningful human insights and digital-first capabilities, which we believe empowers approximately 1.2 billion people to live healthier lives every day.
Our differentiated portfolio of iconic brands—including Tylenol, Neutrogena, Listerine, Johnson’s, Band-Aid, Aveeno, Zyrtec and Nicorette—is built for moments that uniquely matter to our consumers and, we believe, drives positive health outcomes around the world.
We are a global leader at the intersection of healthcare and consumer goods, with a portfolio of iconic brands, operating in some of the most attractive categories in consumer health from both a growth and profitability perspective.
Our consumer health portfolio includes self care, skin care and beauty and essential personal care products, which reflect categories that we believe allow consumers across the world to realize the extraordinary power of everyday care.
| Country | United States |
| IPO Date | May 4, 2023 |
| Industry | Household & Personal Products |
| Sector | Consumer Staples |
| Employees | 22,200 |
| CEO | Thibaut Mongon |
Contact Details
Address:
199 Grandview Road Skillman, NJ 08558 United States | |
| Phone | (908) 874-1200 |
| Website | kenvue.com |
Stock Details
| Ticker Symbol | KVUE |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $22.00 |
| CIK Code | 0001944048 |
| Employer ID | 88-1032011 |
| SIC Code | 2844 |
Key Executives
| Name | Position |
|---|---|
| Thibaut Mongon | Chief Executive Officer and Director |
| Paul Ruh | Chief Financial Officer |
| Luani Alvarado | Chief People Officer |
| Carlton Lawson | Group President, Europe, Middle East and Africa |
| Donna Lorenson | Chief Corporate Affairs Officer |
| Jan Meurer | Chief Growth Officer |
| Matthew Orlando | General Counsel |
| Meredith (Meri) Stevens | Chief Operations Officer |
| Bernardo Tavares | Chief Data & Technology Officer |
| Caroline Tillett | Chief Scientific Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| May 8, 2023 | S-8 | Securities to be offered to employees in employee benefit plans |
| May 8, 2023 | 8-K | Current Report |
| May 4, 2023 | 424B4 | Prospectus |
| May 3, 2023 | EFFECT | Notice of Effectiveness |
| May 3, 2023 | S-1MEF | Registration adding securities to prior Form S-1 registration |
| May 3, 2023 | CERT | Certification by an exchange approving securities for listing |
| May 3, 2023 | 8-A12B | Registration of securities |
| May 1, 2023 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
| Apr 24, 2023 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
| Mar 30, 2023 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |